See also this year's filing and all EDGAR filings for this company.
PDF Report 0001488039_2014_Atossa_Therapeutics_INC.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 0.7641070067883103, 'aggregate_val': 1115900, 'exp_sum': 632558, 'exp_to_value': {'remainder_Revenues': 632558}} |
Graph
Absolute values for 0001488039, Atossa Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 7,413,821 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 4,395,633 |
| 2 | PropertyPlantAndEquipmentNet | 163,147 |
| 3 | remainder_Assets | 36,446 |
| 4 | LiabilitiesCurrent | 1,407,396 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 345,519 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,558,835 |
| 9 | ResearchAndDevelopmentExpense | 1,105,110 |
| 10 | remainder_Expenses | 1,408,097 |
| 11 | remainder_Revenues | 1,115,900 |
| 12 | remainder_NetIncome | 295 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 12,009,047 |
| 1 | Liabilities | 1,407,396 |
| 2 | Expenses | 11,417,561 |
| 3 | Revenues | 1,115,900 |
| 4 | StockholdersEquity | 10,601,651 |
| 5 | NetIncome | -10,301,366 |
| 6 | ComprehensiveNetIncome | -10,301,366 |
| 7 | BaseVar | 12,975,100 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.91 |
| 9 | EconomicCapitalRatio | 2.96 |
Edgar->Model Mapping
Feature Distribution
